Forecast
The analysts' average price target is €271.58 (+1.94%). The median is €271.58 (+1.94%).
| Buy |
Â
2 |
| Hold |
Â
0 |
| Sell |
Â
0 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
UFP Technologies focuses on scaling in medtech outsourcing through acquisitions
UFP Technologies positions itself as a CDMO for medical technology and targets combined annual growth of 12–18% through organic growth and targeted acquisitions. Management aims for a mid‑term gross margin of 28–31% and an adjusted operating margin of 17–20%; annual revenue is around USD 600 million and market capitalization about USD 2.5 billion. UFP reports it has under 1% share of the roughly USD 100 billion outsourcing market but sees long‑term potential and an acquisition pipeline of 5–10 opportunities. Higher inventories and receivables are weighing on short‑term cash flow but, according to management, stem from customer‑bound finished goods and reflect demand. » More on de.investing.com
UFP Technologies beats Q2 expectations, stock climbs premarket
UFP Technologies reported adjusted EPS of $2.92 and revenue of $173.96 million for Q2 2026, comfortably topping consensus estimates. Revenue rose 15.1% year-over-year, organic growth was 12.4%, and gross margin improved to 29.3%. The MedTech business showed broad strength across multiple product lines and customers, and management says operational issues at AJR have been resolved. Management expects organic growth for 2026 within the long-term target range of 6–9%; the stock rose about 11% in premarket trading and surpassed its 52-week high. » More on de.investing.com
UFP Technologies reaches 52-week high at $275.20
UFP Technologies’ stock rose to a new 52-week high of $275.20 as it approaches a market capitalization of $2.12 billion. The share gained 9.13% last week; year-to-date the increase is 19.41% (one‑year return 5.06%). InvestingPro rates the stock as overvalued relative to its fair value and signals an overbought RSI. UFP reported strong Q1 results with EPS of $2.48 versus $2.14 expected, but narrowly missed revenue expectations ($154.2 million vs. $154.6 million); the stock dipped slightly in after-hours trading. » More on de.investing.com
UFP Technologies beats EPS expectations, revenue slightly below forecast
UFP Technologies reported Q4 2025 earnings per share of $2.44 (expectation $2.20) on revenue of $148.92 million (forecast $149.97 million). The stock rose slightly in premarket trading; full‑year 2025 showed revenue growth of 19.5% to $602.8 million and an EPS increase of 15.4%. Workforce inefficiencies pressured margins by about $6.3 million, and management plans cost‑reduction measures. For 2026 the company expects double‑digit growth in the safe patient handling segment and is expanding capacity in the Dominican Republic (new build April 2026). » More on de.investing.com
UFP Technologies positioned for growth as lower rates ease financing pressures
UFP Technologies builds custom-engineered components for medical, aerospace, defense, electronics and transportation markets and reported year‑over‑year revenue and earnings gains with strong 2026 growth projections. The company has a robust balance sheet and consistent free cash flow, which should let it fund expansion as interest rates decline. UFPT stock is flat over 12 months but up about 30% in the past three months after breaking above its 50‑day moving average; technicals show a strengthening MACD but an RSI approaching overbought, indicating potential near‑term pullback risk. » More on investing.com
Financials
In the last quarter, UFP TECHS INC. DL-,01 had revenue of €152.23m and net profit of €18.2m
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 152.23m | 15.59% |
| Gross profit | 44.82m | 23.03% |
| Net profit | 18.2m | 30.38% |
| EBITDA | 24.38m | 0.98% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €2.1bn |
Number of shares | 7.75m |
52-week high/low | €311.78 - €158.45 |
| Dividends | No |
Beta | 1.10 |
P/E ratio | 30.05 |
PEG ratio | 2.22 |
P/B ratio | 4.74 |
P/S ratio | 3.55 |
Company profile
UFP Technologies, Inc. designs and custom manufactures components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics primarily for the medical market. Its single-use and single-patient devices and components are used in a range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The company also provides engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets, which are applied in military uniform and gear components, automotive interior trim, athletic padding, environmentally protective packaging, air filtration, abrasive nail files, and protective cases and inserts. It markets and sells its products in the United States principally through a direct sales force, as well as independent manufacturer representatives. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
| Name | UFP TECHS INC. DL-,01 |
| CEO | Mitchell C. Rock |
| Headquarters | Newburyport,
ma USA |
| Website | |
| Sector | Consumer Discretionary |
| Industry | Household Durables |
| IPO | 17/12/1993 |
| Employees | 4,846 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | UFPT |
Frankfurt | UFP.F |
DĂĽsseldorf | UFP.DU |
MĂĽnchen | UFP.MU |